2017
DOI: 10.1186/s12885-017-3221-9
|View full text |Cite
|
Sign up to set email alerts
|

Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism

Abstract: BackgroundRecent investigations suggest role(s) of human arylamine N-acetyltransferase 1 (NAT1) in breast cancer. Rat NAT2 is orthologous to human NAT1 and the gene products are functional homologs. We conducted in vivo studies using F344.WKY-Nat2 rapid/slow rats, congenic at rat Nat2 for high (rapid) and low (slow) arylamine N-acetyltransferase activity, to assess a possible role for rat NAT2 in mammary tumor susceptibility.MethodsMammary carcinogens, methylnitrosourea (MNU) and 7,12-dimethylbenzanthracene (D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
2

Relationship

4
5

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 48 publications
1
14
0
1
Order By: Relevance
“…Recent meta-analyses suggest the associations of NAT1 genetic polymorphisms with pancreatic (Zhang et al, 2015) and urinary bladder (Dhaini et al, 2017) cancers. Congenic rats with higher arylamine N-acetyltransferase 2 activity (homologous to human NAT1) exhibit greater carcinogen-induced mammary tumor susceptibility (Stepp et al, 2017). Overexpression of NAT1 enhances breast cancer cell proliferation and was associated with a gene signature of epithelial-tomesenchymal transition in breast tumors (Adam et al, 2003;Savci-Heijink et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Recent meta-analyses suggest the associations of NAT1 genetic polymorphisms with pancreatic (Zhang et al, 2015) and urinary bladder (Dhaini et al, 2017) cancers. Congenic rats with higher arylamine N-acetyltransferase 2 activity (homologous to human NAT1) exhibit greater carcinogen-induced mammary tumor susceptibility (Stepp et al, 2017). Overexpression of NAT1 enhances breast cancer cell proliferation and was associated with a gene signature of epithelial-tomesenchymal transition in breast tumors (Adam et al, 2003;Savci-Heijink et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Although this finding is consistent with AcCoA hydrolysis catalyzed by NAT1, it does not provide evidence this is the primary or sole mechanism for the elevation of AcCoA. Rat embryonic fibroblasts from rapid acetylator congenic rats have lower levels of AcCoA than rat embryonic fibroblasts derived from slow acetylator congenic rats [65]. Thus while a direct connection for physiological differences in AcCoA levels cannot be drawn to NAT1 AcCoA hydrolysis, accumulating data suggest that NAT1 may influence endogenous AcCoA levels.…”
Section: Effects Of Small Molecule Nat1 Inhibitor On Mda-mb-231 Breasmentioning
confidence: 61%
“…Penelitian lain juga melaporkan bahwa tikus yang mendapat perlakuan sonde 65mg/kgBB DMBA mengalami peningkatan lebih rendah dibanding yang tidak mendapat induksi DMBA. 15 Penelitian lain juga melaporkan bahwa induksi DMBA tidak menyebabkan perubahan bermakna pada berat badan hewan coba, diantaranya dilaporkan oleh Al-Saeedi 12 yang melaporkan bahwa tidak terjadi perbedaan secara bermakna pada berat badan tikus Sprague-Dawley normal dan yang mendapat induksi DMBA 10 mg/ekor melalui sonde dan diamati tiga minggu sekali selama 12 minggu, namun setelah 12 minggu tikus DMBA+ mengalami penurunan berat badan 5-6% sedang tikus DMBA-mengalami peningkatan berat badan 5-7%. Pada penelitian ini peningkatan berat badan tikus DMBA+ lebih rendah daripada tikus DMBA-dimungkinkan karena tikus DMBA+ mengalami penurunan nafsu makan yang terjadi sejak minggu ke-4 setelah induksi DMBA yang ditandai dengan adanya sisa pakan setiap harinya.…”
Section: Pembahasanunclassified